Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The messaging round mammography usually doesn’t transcend this straightforward three-word chorus: screening saves lives. Medical teams have additionally moved towards earlier breast most...
Video content material above is prompted by the next questions:There are at the moment gallium- and fluorine-based PSMA-PET tracer choices which can be...
